Swedish E-commerce Platform Quickbutik Launches Integrated Payment Solution with Adyen

Swedish e‑commerce platform Quickbutik introduced Quickbutik Checkout, a unified payment solution developed with Adyen, which lets merchants manage payments, payouts and disputes alongside orders and accounting. During a pilot of 5,000 orders, conversion rates rose by an average of 7 %. The service is now open to all merchants, aiming to bring large‑merchant checkout features to businesses of any size.

Italian Oncologists Call on US Biotech to Launch Compassionate-Use Program for Pancreatic Cancer Drug

Aiom is urging US biotech company Revolution Medicines to launch a compassionate‑use program for daraxonrasib, a targeted therapy that has doubled survival in a pancreatic cancer trial. While the drug received FDA approval in the United States, no similar early‑access program exists in Europe, and Revolution Medicines has not submitted a registration dossier to the European Medicines Agency. Aiom and Italian oncologists argue the drug should be provided free of charge to Italian patients pending approval, citing ethical concerns over high import costs.

Italian Startup Drita Capital Partners Launches Search Fund with €640,000 to Acquire Family-Owned SMEs

Drita Capital Partners, founded by former Polimi Graduate School of Management students Nazario Monzillo and Yll Luma, announced the creation of Italy’s first search fund. The fund raised €640,000 from a network of institutional and private investors to spend a 24‑month scouting period aimed at acquiring a high‑potential Italian family‑owned SME in sectors such as ICT, healthcare, manufacturing or food & beverage.

London Deeptech Startup Anemo Labs Secures £700k to Advance AI-Powered Electronic Nose for Disease Detection

London‑based deeptech startup Anemo Labs secured £700k in a pre‑seed round led by Zinc and SFC Capital, with support from Innovate UK, to advance its AI‑driven electronic nose technology for non‑invasive disease screening via volatile organic compounds in urine.

Romanian Surgical Suture Maker BIOSINTEX Completes Major Automation Overhaul With EU Funding

BIOSINTEX SRL, a Romanian manufacturer of high‑performance surgical sutures, together with technology partner TRICUBIQ SOLUTIONS SRL, has completed a 16‑month project worth 18.07 million lei that automates key production processes through robotics, AI and digital tools. The project, financed by the EU‑backed PNRR, enhances BIOSINTEX’s production capacity, quality control and international market position.